Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0276640 (
TEM
)
20,729
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Herein, NH
2
-MIL-125(Ti) (
NMT
) as one of the known stable metal-organic frameworks (MOFs) in aqueous solution was successfully magnetized with CoFe
2
O
4
nanoparticles through the hydrothermal method. The Ag/AgCl as a plasmonic photocatalyst was assembled on the CoFe
2
O
4
/
NMT
(CFNMT) at room temperature by in situ deposition, and photo-reduction methods to improve the photocatalytic activity of CFNMT under LED visible light. The prepared materials were fully characterized by SEM/EDX,
TEM
, FTIR, XRD, UV-DRS, and VSM analysis. Rhodamin B (RhB) was selected as the pollutant model. The results showed that the Ag/AgCl@CFNMT had super-fast degradation ability of RhB molecule due to the synergetic effect between Ag/AgCl and CFNMT in comparison with
NMT
and CFNMT. The introduced Ag/AgCl on the surface of CFNMT increased absorption of photons in the visible region and enhanced the transfer and separation of the produced charge on the contact area between Ag/AgCl and CFNMT. Also, after seven times recycling, besides the simple magnetic separation of Ag/AgCl@CFNMT from liquid media, the composite still showed high photodegradation ability (89%).
...
PMID:In situ deposition of Ag/AgCl on the surface of magnetic metal-organic framework nanocomposite and its application for the visible-light photocatalytic degradation of Rhodamine dye. 3120 Feb 27
Propofol is intravenously administered oil-in-water emulsion stabilized by egg lecithin phospholipids indicated for the induction and maintenance of general anesthesia or sedation. It is generally assumed to be structurally homogenous as characterized by commonly used dynamic light scattering technique and laser diffraction. However, the excessive amount of egg lecithin phospholipids added to the propofol formulation may, presumably, give rise to additional formation of lipid vesicles (i.e., vesicular structures consisting of a phospholipid bilayer). In this study, we investigate the use of high-resolution cryogenic transmission electron microscopy (cryo-TEM) in morphological characterization of four commercially available propofol drug products. The
TEM
result, for the first time, reveals that all propofol drug products contain lipid vesicles and oil droplet-lipid vesicle aggregated structures, in addition to oil droplets. Statistical analysis shows the size and ratio of the lipid vesicles varies across four different products. To evaluate the impact of such morphological differences on active pharmaceutical ingredient (API)'s distribution, we separate the lipid vesicle phase from other constituents via ultracentrifuge fractionation and determine the amount of propofol (2,6-diisopropylphenol) using high performance liquid chromatography (HPLC). The results indicate that a nearly negligible amount of API (i.e.,
NMT
0.25% of labeled content) is present in the lipid vesicles and is thus primarily distributed in the oil phase. As oil droplets are the primary drug carriers and their globule size are similar, the findings of various lipid vesicle composition and sizes among different propofol products do not affect their clinical outcomes.
...
PMID:Coexistence of oil droplets and lipid vesicles in propofol drug products. 3193 73
